Research Update Corner
By Mila McCurrach
At the time of its completion in 2008, the pancreatic cancer genome project (PCGP) represented the most complete genetic analysis of any tumor type. The project has laid the groundwork for new areas of pancreatic cancer investigation. In this issue of RUC, we will discuss three exciting new studies that are shaping the way researchers look at the development, diagnosis and detection of the disease, based on insights gained from the landmark PCGP.
Historically, cancers have been understood and treated based on their physical attributes: what we can “see” about them...The TNM staging system, introduced more than fifty years ago, remains the gold standard for classifying tumors...Although TNM staging and histology remain important to determining therapeutic intervention, new factors such as biomarkers, are playing an increasing role in cancer care.
From global view to bird’s eye view, this installment of Research Update Corner reports on developments in pancreatic cancer research. As you will read, the momentum of pancreatic cancer genomics has caught an international wave on the heels of the landmark Pancreatic Cancer Genome Project, supported in part by The Lustgarten Foundation. I am also pleased to report on the near completion of the Foundation’s $1.25 million Early Detection Biomarker Initiative and tell you about additional activities that are forging progress in the fight.
Much has been going on in the pancreatic cancer scientific community, and as The Foundation’s Research Program Manager, I am delighted to bring you this inaugural installment of Research Update Corner. I hope you will find the column to be a source of information and inspiration in the fight against pancreatic cancer.